According to a recent study conducted by a medical student from Manchester University in the United Kingdom, approximately 50 percent of cystic…
Patrícia Silva, PhD
Patrícia holds a PhD in medical microbiology and infectious diseases from the Leiden University Medical Center, Netherlands, and completed a postdoctoral research fellowship at the Instituto de Medicina Molecular, Lisbon, Portugal. Her work in academia was mainly focused on molecular biology and the genetic traits of infectious agents such as viruses and parasites. Patrícia earned several travel awards to present her work at international scientific meetings. She is a published author of several peer-reviewed science articles.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Patrícia Silva, PhD
Researching and developing therapies to help patients survive cystic fibrosis (CF) remains one of the main goals of…
Xander Bailey is a 18-year-old cystic fibrosis patient who accomplished his dream last weekend thanks to the Make-A-Wish Foundation.
23 year-old Beau Rich is not the first person to plan an inspired cross-country trek across the United States,…
Robert J. Beall, President and CEO of the Cystic Fibrosis Foundation, was invited to a hearing on…
The nonprofit organization Claire’s Place Foundation, founded by a 17-year-old cystic fibrosis patient (CF), was recently awarded “Small Nonprofit…
The first Princeton, IL cystic fibrosis (CF) walk raised over $13,000 recently, $3,000 more than expected. The Great Strides…
Baby Bridget, born on June 27th, became the first baby conceived in Ireland using pre-implantation genetic diagnosis (PGD), a technique used…
Vertex Submits FDA Supplemental New Drug Application for Kalydeco in People with R117H CF Mutation
In the wake of recent promising clinical results, Vertex Therapeutics announced the submission of a supplemental New Drug…
Hemolung Respiratory Assist System (RAS) is an innovative Pittsburgh-made, dialysis-like alternative or supplement to mechanical ventilation that is not approved by…